Work

A phase II study of temozolomide therapy for poor-risk patients aged ⩾60 years with acute myeloid leukemia: low levels of MGMT predict for response

Year: 2007

Type: article

Source: Leukemia

DOI: 10.1038/sj.leu.2404545

Authors: J M Brandwein, L Yang, A D Schimmer, A C Schuh, V Gupta, R A Wells, S M H Alibhai, W Xu, M D Minden

Institutions: University Health Network, University of Toronto, Princess Margaret Cancer Centre

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1972784053

FWCI: 2.129

Cites: 8

Cited by: 23

Related to: 10